SymBio Pharmaceuticals バランスシートの健全性
財務の健全性 基準チェック /66
SymBio Pharmaceuticals has a total shareholder equity of ¥5.2B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥6.1B and ¥910.0M respectively.
主要情報
0%
負債資本比率
JP¥0
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | JP¥5.13b |
| エクイティ | JP¥5.16b |
| 負債合計 | JP¥910.00m |
| 総資産 | JP¥6.07b |
財務の健全性に関する最新情報
We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely
Sep 24
Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation
Feb 09Recent updates
We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely
Sep 24SymBio Pharmaceuticals Limited's (TSE:4582) 31% Share Price Surge Not Quite Adding Up
Aug 06Why Investors Shouldn't Be Surprised By SymBio Pharmaceuticals Limited's (TSE:4582) 28% Share Price Surge
Jun 11Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation
Feb 09If You Had Bought SymBio Pharmaceuticals' (TYO:4582) Shares Five Years Ago You Would Be Down 58%
Dec 18財務状況分析
短期負債: 4582's short term assets (¥6.0B) exceed its short term liabilities (¥906.0M).
長期負債: 4582's short term assets (¥6.0B) exceed its long term liabilities (¥4.0M).
デット・ツー・エクイティの歴史と分析
負債レベル: 4582 is debt free.
負債の削減: 4582 had no debt 5 years ago.
貸借対照表
キャッシュ・ランウェイ分析
過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。
安定したキャッシュランウェイ: 4582 has sufficient cash runway for more than 3 years based on its current free cash flow.
キャッシュランウェイの予測: 4582 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 34.4% each year